Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation

Allergol Immunopathol (Madr). 2013 May-Jun;41(3):204-6. doi: 10.1016/j.aller.2012.04.006. Epub 2012 Oct 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Desensitization, Immunologic* / methods
  • Diphenhydramine / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Eruptions / diagnosis
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / therapy
  • Erythema / chemically induced*
  • Famotidine / therapeutic use
  • Female
  • Humans
  • Injections, Subcutaneous
  • Intradermal Tests
  • Pruritus / chemically induced*
  • Skin Tests
  • Time Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Famotidine
  • Diphenhydramine
  • Adalimumab